President Donald Trump is set to unveil his long-awaited plan for reducing drug prices after more than a year of bold promises to tackle pharmacy costs that are squeezing millions of Americans.
Brian Griffin, CEO of Anthem’s start-up drug unit, IngenioRx, is leaving the Indianapolis-based insurer to become CEO of Diplomat Pharmacy in Michigan.
The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
The not-for-profit that helps low-income Hoosiers get health care coverage and social services lost $60 million in 2016 and cut about 80 jobs last year.
The money is designed to further the work of Dr. Burcin Ekser and his team, who are working to print three-dimensional pig liver tissue from genetically engineered pig liver cells.
The ads for the metastatic breast cancer drug Verzenio show women in their 50s and 60s looking resolute and indomitable, surrounded by smiling friends and family.
The fact naloxone is a prescription drug creates a hurdle for addicts and their families. In addition, many pharmacies and local health departments don’t stock it, and not everyone can afford it.
Carmel-based insurer Baldwin & Lyons Inc. saw a big increase in revenue and premiums written in the first quarter, but a jump in accident losses almost wiped out earnings.
Shares in Athenahealth Inc. surged the most since 2016 after activist investor Elliott Management Corp. bid to acquire the medical company for $160 a share.
State officials said Thursday that they plan to fight Indiana’s opioid crisis by increasing capacity of state-sponsored drug treatment, promoting a campaign on reducing the stigma surrounding drug addiction and treatment, and training more health care workers.
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.
A five-year, $7 million program is led and supported by a coalition of local health institutions, including Eli Lilly and Co., Fairbanks School of Public Health and Eskenazi Health. It is based on a model that Lilly has used in other countries.
The program at Community Hospital East in Indianapolis will have nearly $600,000 state grant money in place to curb the number of female addicts, whose babies often are addicted to drugs.
The Indianapolis-based drugmaker has several pain medications in the pipeline, including potential treatments for migraine headaches, arthritis and chronic back pain.
The Indianapolis pharmaceutical giant is evaluating whether to keep the division, which makes animal-health products, or sell it or take it public. An analyst said it might fetch $16 billion.
Indianapolis-based insurer Anthem Inc. hiked its 2018 forecast after it topped Wall Street expectations with its first quarter performance.
Dr. Jay Hess is one of three finalists to become president at Oregon Health & Science University in Portland, according to The Oregonian.
Indianapolis-based Eli Lilly and Co. on Tuesday reported quarterly revenue and adjusted earnings that exceeded analyst forecasts.
The drug industry set several quarterly records for lobbying spending in the first three months of 2018, but Indianapolis-based Eli Lilly and Co. actually reduced lobbying expenditures.
The Health and Human Services funding is among $485 million recently awarded nationwide to combat heroin and opioid abuse.
